Work

A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.

Year: 2001

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: P C Adamson, B C Widemann, G H Reaman, N L Seibel, R F Murphy, A F Gillespie, F M Balis

Institution: National Cancer Institute

Language: English

Topic: Retinoids in leukemia and cellular processes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: CHILDRENS CANCER GROUP, CHILDRENS CANCER GROUP, CHILDRENS CANCER GROUP, CHILDRENS CANCER GROUP, CANCER IN CHILDREN, CHILDRENS CANCER GROUP, CHILDRENS CANCER GROUP, CHILDRENS CANCER GROUP CHAIRMANS AWARD, CHILDRENS CANCER GROUP, CHILDRENS CANCER GROUP

OpenAlex ID: W2109267124

FWCI: 0.349

Cites: 45

Cited by: 19

Related to: 10